FARINATI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 41.967
AS - Asia 22.681
EU - Europa 10.357
AF - Africa 4.109
SA - Sud America 3.640
OC - Oceania 374
Continente sconosciuto - Info sul continente non disponibili 199
Totale 83.327
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 39.877
SG - Singapore 7.085
CN - Cina 3.985
VN - Vietnam 3.259
HK - Hong Kong 2.545
BR - Brasile 2.087
IT - Italia 1.584
FR - Francia 984
FI - Finlandia 961
DE - Germania 882
IN - India 654
SE - Svezia 572
PL - Polonia 533
GB - Regno Unito 481
NL - Olanda 432
RU - Federazione Russa 412
UA - Ucraina 410
IQ - Iraq 396
TR - Turchia 339
AR - Argentina 321
BD - Bangladesh 317
PK - Pakistan 265
PH - Filippine 262
JP - Giappone 260
SA - Arabia Saudita 245
ZA - Sudafrica 233
MX - Messico 215
AT - Austria 212
ID - Indonesia 205
EC - Ecuador 199
IE - Irlanda 192
ES - Italia 190
CO - Colombia 181
UZ - Uzbekistan 173
CA - Canada 167
EG - Egitto 150
BJ - Benin 149
VE - Venezuela 148
MY - Malesia 146
AE - Emirati Arabi Uniti 143
AL - Albania 139
JO - Giordania 138
CL - Cile 135
CI - Costa d'Avorio 134
KE - Kenya 133
MA - Marocco 133
TH - Thailandia 130
KR - Corea 127
PE - Perù 127
GR - Grecia 126
CR - Costa Rica 125
MU - Mauritius 125
PS - Palestinian Territory 125
RS - Serbia 125
JM - Giamaica 124
DZ - Algeria 122
PY - Paraguay 118
AO - Angola 117
IL - Israele 116
TT - Trinidad e Tobago 116
IR - Iran 113
UY - Uruguay 113
BZ - Belize 112
CM - Camerun 111
LB - Libano 111
NP - Nepal 111
TN - Tunisia 111
GE - Georgia 110
BG - Bulgaria 108
GA - Gabon 108
HR - Croazia 108
MK - Macedonia 108
TW - Taiwan 108
AZ - Azerbaigian 107
BO - Bolivia 107
CV - Capo Verde 107
DO - Repubblica Dominicana 106
SN - Senegal 106
EE - Estonia 105
ME - Montenegro 105
NE - Niger 105
RO - Romania 105
GN - Guinea 104
AU - Australia 103
YE - Yemen 103
BB - Barbados 102
CZ - Repubblica Ceca 102
ET - Etiopia 102
HN - Honduras 102
LY - Libia 102
MN - Mongolia 101
ML - Mali 99
TZ - Tanzania 98
BE - Belgio 97
CW - ???statistics.table.value.countryCode.CW??? 97
GF - Guiana Francese 97
TJ - Tagikistan 97
BY - Bielorussia 96
NI - Nicaragua 96
PT - Portogallo 96
Totale 78.565
Salva come PNG Salva come JPEG
Città #
Fairfield 5.064
Ashburn 4.607
Singapore 4.425
Woodbridge 3.452
San Jose 3.433
Houston 2.895
Hong Kong 2.286
Ann Arbor 2.170
Chandler 1.906
Seattle 1.750
Wilmington 1.704
Cambridge 1.648
Jacksonville 1.272
Ho Chi Minh City 971
Hanoi 752
Princeton 685
Boardman 673
Beijing 623
San Diego 607
Santa Clara 587
Los Angeles 500
Lauterbourg 459
Helsinki 435
New York 393
Roxbury 369
Guangzhou 363
Bytom 354
Medford 341
Nanjing 272
Des Moines 250
Padova 250
São Paulo 205
Da Nang 181
Shanghai 177
Chicago 170
Tokyo 160
Council Bluffs 157
Dublin 153
Tashkent 153
Baghdad 144
Cotonou 143
Dong Ket 140
Haiphong 134
Amsterdam 130
Abidjan 129
Munich 127
Amman 123
Vienna 120
Nairobi 117
Orem 112
London 108
Libreville 105
Dakar 104
Baku 102
Buffalo 102
Conakry 101
Johannesburg 101
Bridgetown 98
Ulan Bator 98
Jeddah 96
Praia 95
Warsaw 94
Managua 93
Milan 93
San José 93
Luanda 92
Montevideo 91
Podgorica 91
Istanbul 90
Norwalk 90
Nuremberg 90
The Dalles 90
Dushanbe 89
Bamako 88
Frankfurt am Main 88
Lahore 88
Niamey 87
Kampala 85
Lusaka 83
Phnom Penh 82
Tirana 82
Addis Ababa 81
Panama City 81
Willemstad 81
Hefei 80
Shenyang 80
Tianjin 80
Castries 79
Harare 79
Rome 79
Andorra la Vella 78
Chennai 78
Kigali 77
Kingston 77
Lima 77
Nanchang 77
Riga 77
Nouakchott 76
Tallinn 76
Havana 75
Totale 52.648
Salva come PNG Salva come JPEG
Nome #
Effects of N-acetyl-L-cysteine in patients with chronic atrophic gastritis and nonulcer dyspepsia: A phase III pilot study 412
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases 321
Autoimmune gastritis: histology phenotype and OLGA staging. 319
Changes in microRNA expression during disease progression in patients with chronic viral hepatitis 315
Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative patients 313
Capecitabine in advanced hepatocellular carcinoma: A multicenter experience 304
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 296
Monofocal hepatocellular carcinoma: How much does size matter? 290
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study 287
Molecular characterization of “sessile serrated” adenoma to carcinoma transition in six early colorectal cancers 286
Abnormal liver function tests in COVID-19 patients: relevance and potential pathogenesis 286
Treatment of hepatocellular carcinoma in the Precision Medicine era: from treatment stage migration to therapeutic hierarchy 280
BRAF p.V600E-specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling 277
LAPAROSCOPIC ABLATION AND SALVAGE TRANSPLANTATION FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA 277
Association of cldn18 protein expression with clinicopathological features and prognosis in advanced gastric and gastroesophageal junction adenocarcinomas 274
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 269
Programmed cell death-ligand 1 (PD-L1) overexpression in ampulla of Vater carcinoma and its pre-invasive lesions 269
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 268
Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1. 268
MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions 267
OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients 267
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: Clinical presentation, treatment and outcome 264
Circulating free DNA in the progression of liver damage to hepatocellular carcinoma 264
miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis 263
Management of hepatocellular carcinoma recurrence after liver transplantation 263
Videolaparoscopic microwave ablation in patients with HCC at a European high-volume center: Results of 815 procedures 261
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 260
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis 257
Oxidative DNA Damage in Barrett Mucosa: Correlation with Telomeric Dysfunction and p53 Mutation. 256
Prospective validation of the Barcelona Clinic Liver Cancer staging system 256
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 256
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 251
Liquid biopsy in hepatocellular carcinoma: Where are we now? 250
PD-L1 expression in gastroesophageal dysplastic lesions 249
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 247
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 246
Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and "normal" liver tissues 245
Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: An intricate pathway. 243
Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis 241
Epstein-Barr virus associated gastric dysplasia: a new rare entity? 240
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 239
Development of retroviral vectors for combined suicide and immunomodulating gene therapy of hepatocellular carcinoma (HCC) 238
Laparoscopic Ablation of Hepatocellular Carcinoma in Cirrhotic Patients Unsuitable for Liver Resection or Percutaneous Treatment: A Cohort Study 238
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 237
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 236
Capecitabine in advanced hepatocellular carcinoma 236
Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccination. 234
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 233
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer. 232
Autoimmune gastritis: Pathologist's viewpoint 232
Pattern of macrovascular invasion in hepatocellular carcinoma 232
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 232
Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma 231
Atrophic gastritis: pathology and endoscopy in the reversibility assessment. 231
Hepatitis C virus eradication with direct acting antiviral improves insulin resistance 230
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series 230
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. 229
Diagnostic and Prognostic Role of Scca-IgM Serum Levels in Hepatocellular Carcinoma (Hcc). 228
Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital 227
Early miR-223 Upregulation in Gastroesophageal Carcinogenesis 226
Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment 225
Duodenal Histological Findings and Risk of Coeliac Disease in Subjects with Autoimmune Atrophic Gastritis: A Retrospective Evaluation 225
Alcohol metabolism in the upper digestive tract: its implications with respect to carcinogenesis. 225
Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease 224
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 224
Coffee and hepatocellular carcinoma: Epidemiologic evidence and biologic mechanisms 223
The survival benefit of liver transplantation in hepatocellular carcinoma patients 222
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteria 222
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 222
Squamous cell carcinoma antigen in human liver carcinogenesis. 221
Years of life that could be saved from prevention of hepatocellular carcinoma 221
Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesis 221
Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens 221
Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. 220
Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria 219
Barrett’s Esophagus and Adenocarcinoma Risk The Experience of the North-Eastern Italian Registry (EBRA) 218
The Unfolded Protein Response and Autophagy in Chronic Liver Diseases, HCC and Metastases 218
The Veneto Region's Barrett's Oesophagus Registry: Aims, methods, preliminary results. 217
Hepatocellular carcinoma in chronic viral hepatitis: Where do we stand? 217
Immunotherapy for gastric premalignant lesions and cancer. 216
Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype 215
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies. 215
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from 20-year multicentre experience in Italy 215
SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differences 215
Retroviral-mediated combined suicide and immunomodulating gene therapy of hepatocellular carcinoma (HCC): An in vitro and in vivo study 214
Objective evidence of gastro-esophageal reflux disease is rare in patients with autoimmune gastritis 212
Oxidative Stress and Inducible Nitric Oxide Synthase Induction in Carcinogenesis 212
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor 211
Proteases in gastrointestinal neoplastic diseases 211
Prognosis of untreated hepatocellular carcinoma. 210
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype 210
Metabolic disorders across hepatocellular carcinoma in Italy 210
Restaging patients with hepatocellular carcinoma before additional treatment decisions: a multicenter cohort study 210
Laparoscopic microwave ablation in patients with hepatocellular carcinoma: A prospective cohort study 208
Bax Inhibitor-1 down-regulation in the progression of chronic liver diseases 207
Autophagy and apoptosis-related genes in chronic liver disease and hepatocellular carcinoma. 207
Percutaneous radiofrequency thermal ablation for hepatocellular carcinoma. 207
Zinc, iron, and peroxidation in liver tissue. Cumulative effects of alcohol consumption and virus-mediated damage--a preliminary report. 206
Barrett's epithelium after antireflux surgery 206
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. 206
Totale 24.236
Salva come PNG Salva come JPEG
Categoria #
all - tutte 232.259
article - articoli 222.970
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.312
Totale 456.541
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.082 0 0 0 0 0 0 0 0 0 0 547 535
2021/20227.028 173 766 949 514 238 409 659 709 277 160 764 1.410
2022/20234.366 928 355 81 508 721 597 53 319 504 35 226 39
2023/20242.623 143 316 269 172 156 298 155 70 188 311 270 275
2024/20259.467 41 587 482 319 1.225 287 379 708 889 424 1.633 2.493
2025/202639.616 1.386 3.427 5.812 6.928 3.441 1.872 5.719 3.688 4.705 2.406 232 0
Totale 83.714